Skip to main content

BioTek, Promega Integrate Platforms

NEW YORK (GenomeWeb News) – The microplate instrument and software maker BioTek Instruments is collaborating with Promega to offer a screening method for cell viability, cytotoxicity, and apoptosis.

The collaboration involves an integration of BioTek's Precision SX Automated Sample Processor and Promega's microwell cell-based assays that will provide a cell-based screening method to "obtain more biologically relevant data per well," the firms said.

BioTek Product Manager Jason Greene said in a statement that the company's sample processing platform cost, "ease of use, and small size lends itself to the small scale automation" of Promega's cell-based assays.

Terms of the collaboration were not disclosed.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.